Zacks Research Cuts Earnings Estimates for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Investment analysts at Zacks Research cut their Q2 2025 EPS estimates for Teladoc Health in a report issued on Tuesday, June 24th. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings per share of ($0.34) for the quarter, down from their prior estimate of ($0.26). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health's Q3 2025 earnings at ($0.25) EPS, Q4 2025 earnings at ($0.22) EPS, FY2025 earnings at ($0.99) EPS, Q1 2026 earnings at ($0.35) EPS, Q2 2026 earnings at ($0.28) EPS, Q3 2026 earnings at ($0.32) EPS, Q4 2026 earnings at ($0.17) EPS, FY2026 earnings at ($1.11) EPS, Q1 2027 earnings at ($0.31) EPS and FY2027 earnings at ($1.07) EPS.

TDOC has been the subject of several other research reports. Stifel Nicolaus reduced their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Wells Fargo & Company cut their price objective on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. Jefferies Financial Group lowered their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Bank of America cut their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Finally, Citigroup reduced their price target on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $9.60.

Teladoc Health Stock Performance

TDOC stock opened at $8.02 on Friday. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The business has a 50-day moving average price of $7.16 and a 200 day moving average price of $8.78. The company has a market capitalization of $1.41 billion, a P/E ratio of -1.35 and a beta of 1.78. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.68 and a quick ratio of 1.64.

Insider Transactions at Teladoc Health

In other news, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the sale, the insider now directly owns 69,773 shares of the company's stock, valued at $478,642.78. The trade was a 7.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of the firm's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 18,656 shares of company stock worth $128,189. Insiders own 0.58% of the company's stock.

Institutional Investors Weigh In On Teladoc Health

Institutional investors and hedge funds have recently modified their holdings of the company. Golden State Wealth Management LLC raised its position in Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after buying an additional 1,690 shares during the last quarter. National Bank of Canada FI increased its stake in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after acquiring an additional 1,581 shares during the period. Whipplewood Advisors LLC purchased a new position in shares of Teladoc Health during the fourth quarter worth $29,000. Lindbrook Capital LLC lifted its position in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the period. Finally, SVB Wealth LLC purchased a new stake in Teladoc Health in the first quarter valued at $37,000. Institutional investors and hedge funds own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.